Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4DED

Aurora A in complex with YL1-038-21

Summary for 4DED
Entry DOI10.2210/pdb4ded/pdb
Related4DEA 4DEB 4DEE
DescriptorAurora kinase A, 2-({2-[(4-carbamoylphenyl)amino]pyrimidin-4-yl}amino)benzamide, 1,2-ETHANEDIOL, ... (4 entities in total)
Functional Keywordsprotein kinase, aurora a, dfg-in, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm, cytoskeleton, centrosome: O14965
Total number of polymer chains1
Total formula weight32893.69
Authors
Martin, M.P.,Zhu, J.-Y.,Schonbrunn, E. (deposition date: 2012-01-20, release date: 2012-08-22, Last modification date: 2023-09-13)
Primary citationLawrence, H.R.,Martin, M.P.,Luo, Y.,Pireddu, R.,Yang, H.,Gevariya, H.,Ozcan, S.,Zhu, J.Y.,Kendig, R.,Rodriguez, M.,Elias, R.,Cheng, J.Q.,Sebti, S.M.,Schonbrunn, E.,Lawrence, N.J.
Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors.
J.Med.Chem., 55:7392-7416, 2012
Cited by
PubMed Abstract: The o-carboxylic acid substituted bisanilinopyrimidine 1 was identified as a potent hit (Aurora A IC(50) = 6.1 ± 1.0 nM) from in-house screening. Detailed structure-activity relationship (SAR) studies indicated that polar substituents at the para position of the B-ring are critical for potent activity. X-ray crystallography studies revealed that compound 1 is a type I inhibitor that binds the Aurora kinase active site in a DFG-in conformation. Structure-activity guided replacement of the A-ring carboxylic acid with halogens and incorporation of fluorine at the pyrimidine 5-position led to highly potent inhibitors of Aurora A that bind in a DFG-out conformation. B-Ring modifications were undertaken to improve the solubility and cell permeability. Compounds such as 9m with water-solubilizing moieties at the para position of the B-ring inhibited the autophosphorylation of Aurora A in MDA-MB-468 breast cancer cells.
PubMed: 22803810
DOI: 10.1021/jm300334d
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.05 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon